Exposure through
arsenic-contaminated air and food caused by the burning of
coal is a major environmental public health concern in Guizhou Province of China. Previous studies have shown that immunological dysfunction is involved in the pathogenesis and
carcinogenesis of
arsenic; however, knowledge regarding effective prevention measures have not been fully examined. The effect of
Ginkgo biloba extract (
EGb761) on
arsenic-induced skin damage of human immortalized keratinocyte cells (HaCaT) was first evaluated in this study. The results showed that 200 μg/mL
EGb761 can reduce the expression of miR-155-5p, and the indicators reflecting
arsenic-induced skin damage (Krt1, Krt6c and Krt10) in
arsenic-exposed cells (P < 0.05), the expression levels of NF-AT1; the indicators reflecting
arsenic-induced immunological dysfunction (IL-2, IFN-γ) in cells; and the levels of secreted
IL-2 and IFN-γ in cell supernatants were significantly increased (P < 0.05). Further randomized controlled double-blind experiments showed that compared to the placebo control group, the expression level of miR-155-5p in the plasma of the Ginkgo biloba intervention group, the indicators in the serum reflecting
arsenic-induced skin damage (Krt1, Krt6c, and Krt10) and the epithelial-mesenchymal transformation (EMT)
vimentin were significantly reduced (P < 0.05), but the levels of NF-AT1 and the indicators reflecting
arsenic-induced immunological dysfunction (IL-2, IFN-γ) and EMT (
E-cadherin) in serum were significantly increased (P < 0.05). Our study provides some limited evidence that Ginkgo biloba L. can increase the expression of NF-AT1 by downregulating the level of miR-155-5p, alleviating immunological dysfunction, and decreasing the expression of EMT
biomarkers, thus indirectly improving
arsenic-induced skin damage.